Patents

     1.     For the prevention of SARS-CoV-2 infection and suppression of Lung Fibrosis including Anti-SPP1 antibody. Gi-Cheon Kim and Ho-Keun Kwon. 10-2023-01799112.

     2     Diagnostic composition for autoimmune diseases including agents that regulate the binding of transcription factors and binding proteins. Gi-Cheon Kim and Ho-Keun Kwon. PCT/KR2023/0093653.

     3.     Immunological checkpoint inhibitor composition containing WNK3 inhibitor as an active ingredient. Gi-Cheon Kim, Ho-Keun Kwon, Hyun-Ju Yoon, Hyun Seok Kim PCT/KR2022/0194774.

     4.     Immunological checkpoint inhibitor composition containing WNK3 inhibitor as an active ingredient. Gi-Cheon Kim, Ho-Keun Kwon, Hyun-Ju Yoon, Hyun Seok Kim 10-2022-01286275.   

     5.     Diagnostic composition for autoimmune diseases including agents that regulate the binding of transcription factors and binding proteins. Gi-Cheon Kim and Ho-Keun Kwon.10-2022-0083183Anti-SPP1 항체를 포함하는 SARs-CoV2 감염 예방 및 Lung Fibrosis 억제용도. 10-2023-0179911